Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
Job Summary
This role will be responsible for commercial finished goods planning and end-to-end planning which includes the analysis and development of supply chain allocations, production schedules, and inventory control.
Duties/Responsibilities
-
Ensure uninterrupted drug supply by translating program needs from commercial demand to production plans.
-
Serve as primary contact and relationship manager for commercial finished goods CMO; responsibilities include support for launch readiness activities, managing contract setup and negotiation, budget establishment and adherence, production planning, operational execution, and on time and in full delivery of program deliverables.
-
Sit on the CMC Launch Team for representation of commercial finished goods CMO
-
Support data gathering and reporting for Sales & Operations Planning (S&OP).
-
Interfaces cross functionally with materials management, logistics, procurement, QA, regulatory, EM, Clinical Operations, Commercial, CMC to understand the impact on the whole supply chain process.
-
Work with the Supply Chain Materials Management Team and External Manufacturing Team to continue to build and maintain a comprehensive inventory of all GMP materials within the Supply Chain of our Clinical Programs.
-
Identify and escalate business critical risks impacting supply and/or timelines with related mitigations and/or possible solutions.
-
Serve as Supply Chain Product Lead (SCPL) on CMC teams responsible for understanding all supply chain related items related to the product.
-
Enable timely resolution of issues associated with operations at the CDMOs including business, manufacturing and/or compliance issues.
-
Responsible for SOW pricing and contract negotiations with CDMOs in collaboration with Strategic Sourcing and Legal.
-
Generate and monitor budget for CDMOs and work with finance and accounting to manage spend and reconciliation.
-
Monitor KPIs for CDMOs and execute business reviews or joint steering committee meetings based on established performance monitoring templates and processes.
Requirements
-
Bachelor’s degree in a relevant field
-
Minimum 8+ years working in biopharmaceutical or relevant
-
Demonstrated knowledge of GMP, quality and supply chain and regulatory requirements.
-
Demonstrated experience in managing commercial end to end planning and finished goods planning.
-
Demonstrated experience with working with external partners (i.e. CMOs).
-
Demonstrated knowledge and comprehensive understanding of supply chain planning, such as S&OP planning, demand planning, supply planning, inventory management.
-
Demonstrated communication and collaboration skills.
-
Ability to work with clinical and commercial planning and drug management systems such as IRT.
-
Ability to work in a high paced and changing environment.
-
Demonstrated ability to analyze supply chain data and identify trends.
-
Strong verbal and written communication skills.
-
Strong interpersonal skills for relationship building and cross functional team management.
-
Strong organizational skills and attention to detail.
-
Strong time management skills with a proven ability to meet deadlines.
-
Strong analytical and problem-solving skills.
-
Proficient with Microsoft Office Suite or related software.
-
Experience with supply planning tools and enterprise resource planning (ERP) systems.
#LI-KO1
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
What We Do
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the CRISPR/Cas9 system. The promise of the CRISPR/Cas9 system is the driving force behind the creation of Intellia. Our founders have a shared belief that the CRISPR/Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. This technology offers the potential for us to develop curative therapeutic options for patients with chronic diseases by addressing the underlying cause of the disease. It can bring new hope and cures to people who now have nowhere to turn for help.
Our combination of deep scientific expertise and clinical development experience, along with our leading intellectual property portfolio, puts Intellia in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products. Intellia has the right people, assets and ambitious vision needed to take full advantage of the CRISPR/Cas9 technology’s attributes – high potency, specificity, simplicity of use, broad applicability, and multifunctional programmability – and accelerate the advancement of curative products into the clinic.
View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/
